215 related articles for article (PubMed ID: 29685967)
1. Germ cell tumour subtypes display differential expression of microRNA371a-3p.
Vilela-Salgueiro B; Barros-Silva D; Lobo J; Costa AL; Guimarães R; Cantante M; Lopes P; Braga I; Oliveira J; Henrique R; Jerónimo C
Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685967
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer.
Myklebust MP; Søviknes AM; Halvorsen OJ; Thor A; Dahl O; Ræder H
Cancer Genomics Proteomics; 2022; 19(2):178-193. PubMed ID: 35181587
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin.
Belge G; Grobelny F; Radtke A; Bodes J; Matthies C; Wülfing C; Dieckmann KP
J Cancer Res Clin Oncol; 2021 Feb; 147(2):435-443. PubMed ID: 33200255
[TBL] [Abstract][Full Text] [Related]
5. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
Fankhauser CD; Christiansen AJ; Rothermundt C; Cathomas R; Wettstein MS; Grossmann NC; Grogg JB; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Moch H; Beyer J; Hermanns T
Br J Cancer; 2022 May; 126(8):1140-1144. PubMed ID: 34912073
[TBL] [Abstract][Full Text] [Related]
6. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
Badia RR; Abe D; Wong D; Singla N; Savelyeva A; Chertack N; Woldu SL; Lotan Y; Mauck R; Ouyang D; Meng X; Lewis CM; Majmudar K; Jia L; Kapur P; Xu L; Frazier AL; Margulis V; Strand DW; Coleman N; Murray MJ; Amatruda JF; Lafin JT; Bagrodia A
J Urol; 2021 Jan; 205(1):137-144. PubMed ID: 32856980
[TBL] [Abstract][Full Text] [Related]
7. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
[TBL] [Abstract][Full Text] [Related]
8. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
van Agthoven T; Eijkenboom WMH; Looijenga LHJ
Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
[TBL] [Abstract][Full Text] [Related]
9. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.
Almstrup K; Lobo J; Mørup N; Belge G; Rajpert-De Meyts E; Looijenga LHJ; Dieckmann KP
Nat Rev Urol; 2020 Apr; 17(4):201-213. PubMed ID: 32157202
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection.
Konneh B; Lafin JT; Howard J; Gerald T; Amini A; Savelyeva A; Woldu SL; Lewis CM; Jia L; Margulis V; Coleman N; Scarpini C; Frazier AL; Murray MJ; Amatruda JF; Bagrodia A
Andrology; 2023 May; 11(4):634-640. PubMed ID: 36254623
[TBL] [Abstract][Full Text] [Related]
11. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ
Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
[TBL] [Abstract][Full Text] [Related]
12. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
[TBL] [Abstract][Full Text] [Related]
13. Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment.
Alonso-Crisostomo L; Trendell J; Ferraresso M; Bailey S; Ward D; Scurlock ZGL; Wenlock SC; Bastos CAP; Jugdaohsingh R; Faria NJ; Enright AJ; Scarpini CG; Coleman N; Murray MJ
Int J Cancer; 2024 Jan; 154(2):372-388. PubMed ID: 37632231
[TBL] [Abstract][Full Text] [Related]
14. CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males.
Spiller CM; Lobo J; Boellaard WPA; Gillis AJM; Bowles J; Looijenga LHJ
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32210110
[TBL] [Abstract][Full Text] [Related]
15. The Diagnostic Accuracy of miR-371a-3p for Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis.
Liu Q; Lian Q; Lv H; Zhang X; Zhou F
Mol Diagn Ther; 2021 May; 25(3):273-281. PubMed ID: 33886084
[TBL] [Abstract][Full Text] [Related]
16. miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up.
Chavarriaga J; Hamilton RJ
Andrology; 2023 May; 11(4):628-633. PubMed ID: 36373757
[TBL] [Abstract][Full Text] [Related]
17. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours.
Dieckmann KP; Hennig F; Anheuser P; Gehrckens R; Viehweger F; Wülfing C; Belge G
Urol Int; 2021; 105(1-2):21-26. PubMed ID: 33049748
[TBL] [Abstract][Full Text] [Related]
18. A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis.
Piao J; Lafin JT; Scarpini CG; Nuño MM; Syring I; Dieckmann KP; Belge G; Ellinger J; Amatruda JF; Bagrodia A; Coleman N; Krailo MD; Frazier AL; Murray MJ
Clin Genitourin Cancer; 2021 Dec; 19(6):469-479. PubMed ID: 34629299
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations of testicular germ cell tumours.
Ilijazi D; Shariat SF; Hassler MR; Lemberger U; Ertl IE
Curr Opin Urol; 2020 Mar; 30(2):264-270. PubMed ID: 31905176
[TBL] [Abstract][Full Text] [Related]
20. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
